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ABSTRACT 
Medicinal plants are the part and parcel of human society to combat against different diseases from the dawn of human civilization. According 
to World Health Organization, approximately 85% population of the developing countries are facing difficulties to afford synthetic drugs and 
are relying on traditional medicines mainly of plant origin in order to maintain their primary health care needs. Plants are being used in various 
disorders. The present pharmacological investigation was undertaken to study the anti-pyretic activity of hydroalcoholic extract of D. hatagirea 
roots (HEDH) & L. stoechas flowers (HELS) in albino rats against yeast induced pyrexia. Hydroalcoholic extract of D. hatagirea roots & L. 
stoechas flowers (5, 50, 300 and 2000 mg/ kg) orally to observe acute toxicity, and observed for 14 days. Eight groups of six animals were used 
for the experiment. The yeast induced pyrexia method was standardized first by injecting 15% yeast suspension (s.c) followed by recording the 
rectal temperature at regular intervals. Then the evaluation of anti-pyretic activity of hydroalcoholic extract of D. hatagirea roots & L. stoechas 
flowers (100, 200mg/kg & 300mg/kg) was carried out by using this standard procedure. The extract of D. hatagirea & L. stoechas plant showed 
a significant (P<0.01) dose dependent antipyretic effect in yeast induced elevation of body temperature in experimental rats.  The data 
generated during study shows that D. hatagirea roots & L. stoechas flowers having significant anti-pyretic activity. 
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The hypothalamus regulates body temperature with a 
delicate balance between heat production and heat loss 
through the set-point control. Infection, tissue damage, 
inflammation, graft rejection, malignancy and other disease 
may elevate the set point to induce fever1. Fever is a complex 
physiologic response which triggered by abnormalities in 
the brain, toxic substances that affect temperature 
regulation, bacterial infections, brain tumors, and 
dehydration. Elevation of the body temperature occurs when 
the concentration of prostaglandin E2 (PGE2) increases 
within parts of the brain. The mechanism of antipyretic 
drugs is inhibiting the cycloxygenase (COX) activity and 
consequently reducing the levels of PGE2. Synthetic 
antipyretic drugs have side effects2. Therefore, it is worthed 
to searching herbal medicines that are equally efficacious 
and comparatively side effects free, as substitutes for 
synthetic drugs, in recent years herbal medicine is a major 
component in all traditional medicine systems, and a 
common element in Siddha, Ayurvedic, Homeopathic, 
Naturopathic, Traditional Chinese medicine, and Native 
American medicine. Considerable efforts have been directed 
towards the development of natural products from various 
plant sources3 [3]. Dactylorhiza hatagirea (D.Don) Soo 
belongs to the family Orchidaceae. D. hatagirea is a 
Himalayan endemic medicinal orchid which is found in 
Hindu Kush Himalaya range. Its occurrence is sub-alpine and 
alpine zones from 2800-4200 m above from sea level4. Other 
than Nepal Himalayas, it occurs in the same altitudinal 
ranges of India, Pakistan, Bhutan and China also. It is a 
terrestrial, erect herb, up to 60 cm high, with palmately 
divided tuberoids. Leaves are broadly lanceolate or oblong-
lingulate or elliptic. Flowers purplish-lilac, rose or rarely 
white, in many-flowered densely cylindric inflorescence5. 
The special character of this plant is that, it remains erect in 
excessive snowfall. Tubers are sweet, cooling, emollient, 
astringent, aphrodisiac, demulcent, rejuvenating and nervine 
tonic. They are useful in diabetes, hemiplegia, dysentery, 
phthisis, chronic diarrhoea, seminal weakness, neurasthenia, 
cerebropathy, emaciation and general debility. A decoction 
of tuber is given in colic pain. Powder is used to relieve 
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fever; it is sprinkled over wounds to check bleeding. Root is 
also used in urinary troubles; also used as farinaceous food6. 
Tubers contain a glycoside, a bitter substance, starch, 
mucilage, albumen, a trace of volatile oil and ash7. 
Chemically, dactylorhins A-E, dactyloses A and B and lipids 
etc. are found as major constituents. Lavandula genus is an 
important member of Labiatae (Lamiaceae) family. 
Lavandula species are widely distributed in the 
Mediterranean region and cultivated in France, Spain and 
Italy. In Turkey mainly two species, L. angustifolia and L. 
stoechas and their subspecies and hybrid forms grow wildly 
or they are cultivated8,9. L. stoechas is known as French 
lavender10 and it is used by people for various diseases of 
central nervous system (epilepsy and migraine), treatment 
of wounds, reduce to blood sugar. It is also used as 
antispasmodic, antiseptic, antimicrobial, sedative, diuretic 
and analgesic agents11-13. Lavender has also positive effects 
on urinary infections, cardiac diseases and eczema12. 
Furthermore, nowadays the lavender species are extensively 
cultivated throughout the world in order to be commonly 
employed in perfumery and cosmetic industry12-14, where 
especially their oil extracted is used. Lavender essential oil is 
used in aromatherapy and in the flavouring and fragrance 
industry15,16. Lavender has been extensively studied from 
the phytochemical point of view, limited studies being 
devoted to pharmacological aspects17. For medicinal 
purposes its aerial parts are used. The aerial parts contain 
oleanolic acid, ursolic acid, vergatic acid, β-sitosterol, α-
amyrin, α-amyrin acetate, lupeol, erythrodiol and flavonoids, 
acacetin and vitexin18, as well as two longipinane 
derivatives, longipin-2- ene-7β,9α-diol-1-one and longipin-2-
ene-7β,9α-diol-1-one-monoacetate19. Recent studies also 
suggested that Lavandula species have antioxidant and local 
anaesthetic activity20. Since the antipyretic activity effect of 
D. hatagirea roots & L. stoechas flowers has been 
experimentally not confirmed. So the present study has been 
carried out to evaluate and compare the in vivo antipyretic 
activity of the hydroalcoholic extract of D. hatagirea roots & 
L. stoechas flowers by yeast induced pyrexia method. 
MATERIALS AND METHODS 
Plant material 
The roots of plant D. hatagirea and aerial part of L. stoechas 
were collected from local area of Bhopal (M.P), India in the 
month of Jan 2017. The taxonomical identification and 
authentication of the plant material was done by Dr. Zia Ul 
Hasan, Department of Botany, SAFIA College Bhopal (M.P). 
The specimens of voucher have been submitted and 
preserved in the herbarium of SAFIA College Bhopal (M.P). 
Chemical reagents 
All the chemicals used in this study were obtained from Hi 
Media Laboratories Pvt. Ltd. (Mumbai, India), Sigma Aldrich 
Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem. Ltd. 
(Mumbai, India) and SRL Pvt. Ltd. (Mumbai, India).All the 
chemicals used in this study were of analytical grade. 
Preparation of extract 
Defatting of plant material 
Powdered material of L. stoechas and D. hatagirea were 
shade dried at room temperature. The shade dried plant 
material was coarsely powdered and subjected to extraction 
with petroleum ether (60-80°C) in a soxhlet apparatus. The 
extraction was continued till the defatting of the material 
had taken place.  
 
 
Extraction by hot continuous percolation process 
100 gm of L. stoechas and D. hatagirea dried material were 
exhaustively extracted with 80% ethanol (Hydroalcoholic) 
using hot continuous percolation for 24 hrs. Appearance of 
colorless solvent in the siphon tube was taken as the end 
point of extraction. The extracts were concentrated to ¾ of 
its original volume by distillation. The concentrated extracts 
were taken in a china dish and evaporated on a thermostat 
controlled water bath till it forms a thick paste and stored in 
an air tight container free from any contamination until it 
was used. Finally the percentage yields were calculated of 
the dried extracts21. 
Experimental animals 
Swiss albino male mice (20-25 g) were group housed (n= 6) 
under a standard 12 hr light/dark cycle and controlled 
conditions of temperature and humidity (25±2°C, 55-65%). 
Mice received standard rodent chow and water ad libitum. 
Animas were acclimatized to laboratory conditions for 7 
days before carrying out the experiments. All the 
experiments were carried in a noise-free room between 
08.00 to 15.00hr. Separate group (n=6) of mice was used for 
each set of experiments. The animal studies were approved 
by the Institutional Animal Ethics Committee (IAEC), 
constituted for the purpose of control and supervision of 
experimental animals by Ministry of Environment and 
Forests, Government of India, New Delhi, India. 
Acute toxicity studies 
Acute toxicity studies were conducted on Swiss albino mice 
as per the Organization for Economic Co-operation and 
Development (OECD) 423 guidelines22. The hydroalcoholic 
extract of both plants at doses of 5, 50, 300 and 2000 mg/ kg 
body weight were administered to four groups of rats (n = 6) 
after overnight fasting. The animals were observed twice on 
the day of the dosing and once daily thereafter for 14 days. 
Animals were observed daily for mortality and for gross 
changes in activity and behavioral pattern. They were also 
observed for the presence of tremors, convulsions, 
salivation, diarrhea and lethargy. The hydroalcoholic extract 
of D. hatagirea roots & L. stoechas flowers was found to be 
non-toxic up to a dose of 2000 mg / kg and did not cause 
death, therefore it was considered to be safe. Hence, one-
tenth of this dose, that is, 200 mg/kg body weight and half of 
the one-tenth dose, that is, 100 mg/kg, as also 3times of this, 
that is, 300mg/kg, were used for the elucidation of anti-
pyretic activity. 
Brewer’s yeast-induced pyrexia 
Before experimentation rectal temperature of mice were 
recorded by inserting a well lubricated bulb of a 
thermometer in the rectum. Hyperpyrexia was induced in 
mice by subcutaneous injection of 10 ml/kg b.w. of a 15% 
aqueous suspension of brewer's yeast in the back below the 
nape of the mice. Pre-drug control temperatures were taken 
at 24 h after the yeast injection to determine the pyretic 
response of yeast. HELS (100, 200 and 300 mg/kg, p.o.), 
HEDH (100, 200 and 300 mg/kg, p.o.) and aspirin (100 
mg/kg body weight) served as the reference drug given 
orally 24 h after the yeast injection. The temperatures were 
recorded at 1-4 h after the drug treatment23, 24. The 
followings are group distribution, 
Group I – Control mice (Normal saline 5 ml/kg) 
Group II – Standard (Aspirin 100 mg/kg/ p.o.) 
Group III – HELS 100 mg / kg, p.o. 
Group IV – HELS 200 mg / kg, p.o. 
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Group V – HELS 300 mg / kg, p.o. 
Group VI – HEDH 100 mg / kg, p.o. 
Group VII – HEDH 200 mg / kg, p.o. 
Group VIII – HEDH 300 mg / kg, p.o. 
Statistical analysis 
The values were expressed as mean ± SEM (n=6). The 
statistical significance was assessed using one-way analysis 
of variance (ANOVA) followed by Tukey’s test and P<0.05 
were considered to be statistically significant. 
RESULTS AND DISCUSSIONS 
The effect of hydroalcoholic extract of HELS and HEDH plant 
on yeast induced pyrexia has been shown in Table 1 and 2. 
Treatment with extracts at dose of 100, 200 mg/kg and 300 
mg/kg body weight and aspirin at dose of, 100mg/kg 
decreased body temperature of yeast induced mice in a 
dose-dependent manner. The antipyretic effect started as 
from the first hour and the effect was maintained for 4 h, 
after administration of the extract. The results obtained from 
both standards and extracts treated groups were compared 
with the control group. A significant reduction in the yeast 
elevated rectal temperature was observed in the test drug. 
Fever can be induced in experimental animals by 
intravenous or subcutaneous injection of pyrogens. To 
evaluate the antipyretic activity of test drugs, the most 
commonly employed method to induce fever involves 
injection of lipopolysaccharides (LPS) or brewer's yeast in 
rabbits or rats. Antipyretic are the agents, which reduce the 
elevated body temperature. Regulation of body temperature 
requires a delicate balance between production and loss of 
heat, and the hypothalamus regulates the set point at which 
body temperature is maintained. In fever this set point 
elevates and a drug like aspirin does not influence body 
temperature when it is elevated by the factors such as 
exercise or increase in ambient temperature25, 26. Yeast 
induced fever is called pathogenic fever. Its etiology includes 
production of prostaglandins, which set the 
thermoregulatory center at a lower temperature. The 
present results show that both extract possesses a 
significant antipyretic effect in yeast- provoked elevation of 
body temperature in mices and its effect is comparable to 
that of aspirin (standard drug). So inhibition of 
prostaglandin synthesis could be the possible mechanism of 
antipyretic action as that of aspirin. Also, there are several 
mediators or multiprocesses underlining the pathogenesis of 
fever. Inhibition of any of these mediators may bring about 
antipyretic effect27, 28. 
 
Table 1 Effect of HELS and HEDH extract on Yeast-induced hyperpyrexia (before drug admin.) in mice 
S.N. Groups Dose Temp. Before yeast 
admin. 
Pre-drug control, 1h before 
drug admin. 
1.  Normal 5 mL/kg/p.o. 95.56±3.88 101.27±0.34 
2.  Aspirin 100 mg/kg/ p.o. 95.43±4.48 100.17±0.30 
3.  HELS-100 100 mg/kg, p.o. 96.13±5.62 100.10±0.85 
4.  HELS-200 200 mg/kg, p.o. 95.57±4.35 100.07±0.29 
5.  HELS-300 300 mg/kg, p.o. 95.23±4.49 100.50±0.12 
6.  HEDH-100 100 mg/kg, p.o. 96.12±5.61 100.08±0.84 
7.  HEDH-200 200 mg/kg, p.o. 95.56±5.34 100.05±0.28 
8.  HEDH-300 300 mg/kg, p.o. 95.23±4.48 100.45±0.10 
 
Table 2 Effect of HELS and HEDH extract on Yeast-induced hyperpyrexia (After drug admin) in mice 
Groups Dose Temp. Before 
yeast admin. 
Rectal temp. After drug admin. (% decrease) 
1 h 2 h 3 h 4 h 
Normal 5 ml/kg/p.o. 95.56±3.88 101.10±5.42 101.07±4.38 101.17±5.00 101.07±5.44 
Aspirin 100 mg/kg/ p.o. 95.43±4.48 98.20±5.49*** 96.00±5.56*** 95.50±4.40*** 92.47±4.42*** 
HELS-100 100 mg/kg, p.o. 96.13±5.62 99.57±4.57** 98.80±6.35** 97.33±5.52** 96.57±3.58** 
HELS-200 200 mg/kg, p.o. 95.57±4.35 99.30±4.29** 98.57±4.29** 97.00±4.15** 96.40±5.20** 
HELS-300 300 mg/kg, p.o. 95.23±4.49 99.00±5.29** 97.89±5.67*** 96.17±4.44*** 94.00±5.50*** 
HEDH-100 100 mg/kg, p.o. 96.12±5.61 99.56±6.56** 98.89±5.34** 97.32±4.52** 96.96±4.58* 
HEDH-200 200 mg/kg, p.o. 95.56±5.34 99.32±5.28** 98.00±6.28*** 97.12±6.14** 96.39±5.21** 
HEDH-300 300 mg/kg, p.o. 95.23±4.48 99.00±4.28** 97.70±4.66*** 96.16±5.43** 94.40±5.49*** 
Values are expressed as mean±S.E.M. (n = 6). Values are statistically significant at***P<0.001, **P<0.01, *P<0.05 vs. control group respectively 
(One-way ANOVA followed by Tukey’s post hoc test).  
 
CONCLUSION  
The present investigation it may be concluded that the 
hydroalcoholic extract of HELS and HEDH have antipyretic 
activity. In this study no attempt was made to ascertain the 
mechanism of the observed antipyretic activity. However, it 
can be suggested that it may be acting through either the 
peripheral or central mechanism enumerated above. It is 
also possible that both the mechanisms may be involved. 
Further, study regarding isolation and characterization of 
active principle responsible for antipyretic activity are under 
planning in our laboratory. 
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